查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468359

按类型（戈谢氏症1 型、戈谢氏症2 型、戈谢氏症3 型等）、诊断和治疗（诊断、治疗）、最终用户（医院、专科诊所、家庭护理等）和地区分類的戈谢病市场2024-2032

Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球戈谢氏症市场规模达17亿美元。越来越多的戈谢氏症患者、广泛的研发（R＆D）活动以及药物的容易取得是推动市场发展的一些关键因素。

戈谢氏症，也称为溶小体储存障碍，是一种罕见的遗传代谢紊乱，影响身体分解和储存脂肪的能力。它是由葡萄糖脑苷脂酶缺乏引起的，该酶会分解体内的葡萄糖脑苷脂脂肪化学物质。它与脾臟和肝臟肿大、贫血、容易瘀伤和出血、肺部问题、疲劳、癫痫发作和骨骼异常有关。它是透过各种身体检查、病史和实验室测试（例如血液和影像学测试）以及基因测试来确诊，以确认基因中是否存在突变。戈谢氏症可以透过药物、注射、酵素替代疗法 (ERT)、骨髓移植和底物减少疗法 (SRT) 来治疗，有助于最大限度地减少与症状相关的疼痛并提高生活品质。

戈谢氏症市场趋势：

目前，个体遗传异常盛行率的增加和戈谢氏症患者数量的增加是推动全球市场成长的主要因素之一。此外，日益增长的老化人口更容易患上这些疾病，导致对戈谢氏症治疗的需求增加。此外，为戈谢氏症治疗提供经济资助、减少医疗费用的健康保险政策的实施也有所增加。除此之外，人们对戈谢氏症、其症状、诊断以及治疗方案的便利性的认识不断增强，正在对市场产生积极影响。此外，许多国家的政府正在投资研发 (R&D) 活动，以研究戈谢氏症并开发新的治疗方法。他们也采取措施向所有人提供优质的医疗设施。再加上诊断技术的显着改进，正在为市场创造积极的前景。除此之外，人们越来越认识到 ERT 治疗替代方案（例如有助于分解葡萄糖脑苷脂并减少累积的口服疗法）的便利性，也促进了市场的成长。它们通常涉及非处方药 (OTC) 和处方药，用于缓解与戈谢氏症相关的疼痛。

本报告回答的关键问题

  • 全球戈谢病市场有多大？
  • 2024-2032年全球戈谢氏症市场的预期成长率是多少？
  • 推动全球戈谢氏症市场的关键因素是什么？
  • COVID-19 对全球戈谢氏症市场有何影响？
  • 根据类型，全球戈谢氏症市场的细分情况如何？
  • 全球戈谢氏症市场的关键地区有哪些？
  • 全球戈谢氏症市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球戈谢氏症市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 1 型戈谢病
    • 市场走向
    • 市场预测
  • 2 型戈谢病
    • 市场走向
    • 市场预测
  • 戈谢氏症 3 型
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：透过诊断与治疗

  • 诊断
    • 市场走向
    • 关键环节
      • 体检
      • 血液检查
      • 影像学检查
      • 怀孕前筛检和产前检测
      • 其他的
    • 市场预测
  • 治疗
    • 市场走向
    • 关键环节
      • 手术
      • 药物
      • 其他的
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 专科诊所
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ISU Abxis Co. Ltd.
    • Johnson & Johnson
    • Pfizer Inc.
    • Protalix Biotherapeutics
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112024A6807

The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. Increasing number of patients suffering from Gaucher disease, extensive research and development (R&D) activities, and the easy availability of drugs represent some of the key factors driving the market.

Gaucher disease, also known as lysosomal storage disorder, is a rare genetic metabolic disorder that affects the ability of the body to break down and store fats. It is caused by glucocerebrosidase deficiency, which breaks down glucocerebroside fatty chemicals in the body. It is associated with an enlarged spleen and liver, anemia, easy bruising and bleeding, lung problems, fatigue, seizures, and bone abnormalities. It is diagnosed through various physical examinations, medical history, and laboratory tests, such as blood and imaging tests, and genetic testing to confirm the presence of a mutation in the gene. Gaucher disease can be treated using medications, injections, enzyme replacement therapy (ERT), bone marrow transplantation, and substrate reduction therapy (SRT), which aid in minimizing the pain associated with the symptoms and improve the quality of life.

Gaucher Disease Market Trends:

At present, the increasing prevalence of genetic abnormalities among individuals and the rising number of patients suffering from Gaucher disease represent one of the major factors bolstering the market growth around the world. Moreover, the growing aging population that is more prone to developing these medical disorders is resulting in an increasing demand for Gaucher disease treatment. In addition, there is a rise in the implementation of health insurance policies that provide financial assistance for Gaucher disease treatment and reduce medical expenses. Apart from this, the growing awareness about Gaucher disease, its symptoms, diagnosis, and the easy availability of the treatment options is influencing the market positively. Furthermore, governments of numerous countries are investing in research and development (R&D) activities to study Gaucher disease and develop new treatments. They are also undertaking measures to offer quality healthcare facilities that are accessible to all. This, coupled with significant improvements in the diagnostic technologies, is creating a positive outlook for the market. Besides this, the rising awareness about the easy availability of ERT treatment alternatives like oral therapies that help break down glucocerebroside and reduce the accumulation is contributing to the growth of the market. They generally involve generic drugs that are readily available over the counter (OTC) and by prescription for relieving pain associated with Gaucher disease.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global Gaucher disease market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type, diagnosis and treatment, and end user.

Type Insights:

Gaucher Disease Type 1

Gaucher Disease Type 2

Gaucher Disease Type 3

Others

The report has provided a detailed breakup and analysis of the Gaucher disease market based on the type. This includes Gaucher disease type 1, Gaucher disease type 2, Gaucher disease type 3, and others. According to the report, Gaucher disease type 1 represented the largest segment.

Diagnosis and Treatment Insights:

Diagnosis

Physical Exam

Blood Tests

Imaging Tests

Preconception Screening and Prenatal Testing

Others

Treatment

Surgery

Medication

Others

A detailed breakup and analysis of the Gaucher disease market based on the diagnosis and treatment has also been provided in the report. This includes diagnosis (physical exam, blood tests, imaging tests, preconception screening and prenatal testing, and others) and treatment (surgery, medication, and others).

End User Insights:

Hospitals

Specialty Clinics

Homecare

Others

The report has provided a detailed breakup and analysis of the Gaucher disease market based on the end user. This includes hospitals, specialty clinics, homecare, and others.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for Gaucher disease. Some of the factors driving the North America Gaucher disease market included increasing prevalence of genetic abnormalities, the presence of a well-established healthcare infrastructure, the integration of advanced medical technologies, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global Gaucher disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include ISU Abxis Co. Ltd., Johnson & Johnson, Pfizer Inc., Protalix Biotherapeutics, Sanofi S.A, Takeda Pharmaceutical Company Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global Gaucher disease market?
  • 2. What is the expected growth rate of the global Gaucher disease market during 2024-2032?
  • 3. What are the key factors driving the global Gaucher disease market?
  • 4. What has been the impact of COVID-19 on the global Gaucher disease market?
  • 5. What is the breakup of the global Gaucher disease market based on the type?
  • 6. What are the key regions in the global Gaucher disease market?
  • 7. Who are the key players/companies in the global Gaucher disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Gaucher Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gaucher Disease Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Gaucher Disease Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Gaucher Disease Type 3
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Diagnosis and Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Physical Exam
      • 7.1.2.2 Blood Tests
      • 7.1.2.3 Imaging Tests
      • 7.1.2.4 Preconception Screening and Prenatal Testing
      • 7.1.2.5 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Surgery
      • 7.2.2.2 Medication
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Homecare
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 ISU Abxis Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Johnson & Johnson
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Pfizer Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Protalix Biotherapeutics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Sanofi S.A
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Takeda Pharmaceutical Company Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Gaucher Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Gaucher Disease Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Gaucher Disease Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Gaucher Disease Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Gaucher Disease Market: Breakup by Diagnosis and Treatment (in %), 2023
  • Figure 6: Global: Gaucher Disease Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Gaucher Disease Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Gaucher Disease (Gaucher Disease Type 1) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Gaucher Disease (Gaucher Disease Type 1) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Gaucher Disease (Gaucher Disease Type 2) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Gaucher Disease (Gaucher Disease Type 2) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Gaucher Disease (Gaucher Disease Type 3) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Gaucher Disease (Gaucher Disease Type 3) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Gaucher Disease (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Gaucher Disease (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Gaucher Disease (Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Gaucher Disease (Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Gaucher Disease (Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Gaucher Disease (Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Gaucher Disease (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Gaucher Disease (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Gaucher Disease (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Gaucher Disease (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Gaucher Disease (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Gaucher Disease (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Gaucher Disease (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Gaucher Disease (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Gaucher Disease Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Gaucher Disease Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Gaucher Disease Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Gaucher Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 78: Global: Gaucher Disease Industry: Value Chain Analysis
  • Figure 79: Global: Gaucher Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gaucher Disease Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Gaucher Disease Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Gaucher Disease Market Forecast: Breakup by Diagnosis and Treatment (in Million US$), 2024-2032
  • Table 4: Global: Gaucher Disease Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Gaucher Disease Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Gaucher Disease Market: Competitive Structure
  • Table 7: Global: Gaucher Disease Market: Key Players